Evidence map›Paper›PMID 23553833›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2013

Proteome-wide profiling of activated transcription factors with a concatenated tandem array of transcription factor response elements.

Chen Ding, Doug W Chan, Wanlin Liu, Mingwei Liu, Dong Li, Lei Song, Chonghua Li, Jianping Jin, Anna Malovannaya, Sung Yun Jung and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 115 citations in OpenAlex.

  1. MAP2K6 reprograms NADCell death & disease · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Region- and Cell-type-Resolved Multiomic Atlas of the Heart.Molecular & cellular proteomics : MCP · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Frontiers in molecular biosciences · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Proteome-Wide Profiling of Readers for DNA Modification.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Chen DingState Key Laboratory of Proteomics, Beijing Proteome Research Center, Beijing Institute of Radiation Medicine, Beijing 100850, China.
Doug W Chan
Wanlin Liu
Mingwei Liu
Dong Li
Lei Song
Chonghua Li
Jianping Jin
Anna Malovannaya
Sung Yun Jung
Bei Zhen
Yi Wang
Jun Qin
Baylor College of Medicine · USBeijing Proteome Research Center · CNThe University of Texas Health Science Center at Houston · USNational Institutes for Food and Drug Control · CN

Funding

ProteomicsU19DK062434 · NIDDK · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI MANGELSDORF, DAVID J · 2002 to 2011
$37.4M
NIDDK NIH HHS U19 DK062434NIDDK NIH HHS U19-DK62434
6 · The paper itself

Abstract

Transcription factors (TFs) are families of proteins that bind to specific DNA sequences, or TF response elements (TFREs), and function as regulators of many cellular processes. Because of the low abundance of TFs, direct quantitative measurement of TFs on a proteome scale remains a challenge. In this study, we report the development of an affinity reagent that permits identification of endogenous TFs at the proteome scale. The affinity reagent is composed of a synthetic DNA containing a concatenated tandem array of the consensus TFREs (catTFRE) for the majority of TF families. By using catTFRE to enrich TFs from cells, we were able to identify as many as 400 TFs from a single cell line and a total of 878 TFs from 11 cell types, covering more than 50% of the gene products that code for the DNA-binding TFs in the genome. We further demonstrated that catTFRE pull-downs could quantitatively measure proteome-wide changes in DNA binding activity of TFs in response to exogenous stimulation by using a label-free MS-based quantification approach. Applying catTFRE on the evaluation of drug effects, we described a panoramic view of TF activations and provided candidates for the elucidation of molecular mechanisms of drug actions. We anticipate that the catTFRE affinity strategy will find widespread applications in biomedical research.

Indexed as

Cell LineChromatography, LiquidComputational BiologyDNADNA PrimersGene Expression RegulationHumansProtein Array AnalysisProteomeResponse ElementsTandem Mass SpectrometryTranscription FactorsDNADNA PrimersProteomeTranscription Factors

Identifiers

PMID23553833
PMCPMC3637693
OpenAlexW2021178906

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.